Popular Articles

New Approach To Treating Heart Attacks Reduces Risk Of Life-Threatening Complications
Transferring heart attack patients to specialized hospitals to undergo angioplasty within six hours after receiving clot-busting drugs reduces the risk of life-threatening complications including repeat heart attacks, according to a new study from St. Michael"s Hospital and Southlake Regional Hospital.
pharmacy online
Weakening IP Would Threaten R&D Investment
A proposal to dramatically weaken intellectual property legislation could lead to the loss
News of the day
Washington Post Column Examines Issues Surrounding Supreme Court Confirmation Hearings
"When a Supreme Court nominee such as Judge Sonia Sotomayor comes before the Senate for confirmation, she is promised a full, fair hearing," yet "every nominee"s path is booby-trapped by the history of previous confirmation battles," Washington Post columnist David Broder writes. Broder examines prior confirmation hearings, noting that the "[o]ne thing that may make it harder to forget the partisan and ideological battles of the past is that President Obama found reasons to oppose" Chief Justice John Roberts and Justice Samuel Alito while he was in the Senate.During Roberts" confirmation hearing, Obama said that although he was "sorely tempted to vote for Judge Roberts," he had issues with Roberts in cases where "precedent and rules of construction" are insufficient and where justice "can only be determined on the basis of one"s deepest values." Obama added that the rights of women and minorities are dependent on cases in which "the critical ingredient is supplied by what is in the judge"s heart." Obama said Roberts" record on women"s rights and other issues was not strong enough to quell doubts about Roberts" "deepest values."Broder continues, "Based on the Obama precedent, the White House can hardly complain if Republicans push beyond the question of Sotomayor"s qualifications and examine her values -- and her biases." He concludes, "Someday, the Senate may again be satisfied to examine only professional credentials, recognizing the uncertain dynamics of a nine-person bench," but while past precedents survive, "that is not likely" (Broder, Washington Post, 6/4).
Health Insurance

AARP Ramps Up Effort To Close Medicare Doughnut Hole One In Five Fall Into The Gap, But Few Climb Out

WASHINGTON-AARP"s Health Action Now campaign turns its attention this week to the growing problem of prescription drug costs and reducing the gap in prescription drug coverage for people in Medicare. Closing the Part D doughnut hole could save people in the program thousands of dollars in drug costs and keep them healthier by ensuring they can afford their medications. The Association is pressing lawmakers to lower individuals" drug costs as a part of health reform, including closing the doughnut hole-which forces more than 3 million people in Medicare to pay their full drug costs each year-and increasing the availability of generic drugs, particularly generic versions of costly biologics. "Prescription drug coverage has literally been a life-saver for people in Medicare, but the widening doughnut hole is still leaving too many Americans on their own to face skyrocketing drug costs," said AARP Executive Vice President Nancy LeaMond. "We know that higher costs lead people to skip doses or give up their prescriptions entirely, putting their health in jeopardy and driving up long-term costs." AARP is working with leaders on Capitol Hill to close the doughnut hole, which is predicted to top $6,000 by 2016. Today, 3.4 million people fall into the gap each year, while only 15 percent of those are able to get out and receive catastrophic coverage. AARP is also fighting to bring more generic drugs to market, particularly generic versions of costly biologic drugs used to treat diseases like cancer and multiple sclerosis. Unlike traditional chemical drugs, biologics are created from living organisms and have no FDA approval process for generic versions. Without generic competition, biologic makers are free to charge thousands of dollars per month, even for drugs that have been on the market for many years. LeaMond added: "Since the 1980s, safe, affordable generic drugs have helped Americans save billions of dollars on their health care bills. With biologics now making up a large and growing share of the market, it"s time to bring those same savings to people taking these breakthrough drugs while protecting medical innovation." AARP has endorsed the "Promoting Innovation and Access to Life-Saving Medicine Act" (H.R. 1427/S. 726), which would create an FDA approval process-similar to that for traditional prescription drugs-for generic biologic drugs. In addition, AARP is working to help the four million low-income Americans who are eligible for the Medicare Part D Low-Income Subsidy, which greatly reduces a person"s drug costs and has no gap in coverage. The Association is fighting to increase access to the benefit by raising and ultimately eliminating the asset limit, expanding eligibility, standardizing eligibility rules, and raising awareness about the program. AARP


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):